Cinnarizin 25mg Domesco medicine for peripheral vascular disease (3 blisters x 10 tablets)

Dosage form Box of 3 blisters x 10 tablets
Specifications Cinnarizine
Ingredient Vomiting/nausea, raynaud syndrome, tinnitus, vestibular disorders, migraine, teeth loss, motion sickness, dizziness

Ingredient

Composition information	Content
Cinnarizine	25mg

Uses

indications

cinnarizin is indicated in peripheral vascular disease with symptoms such as regression, limb cold and vasomotor spasms.

Pharmacokology

There is no reported data.

Dynamic pharmacokinetics

There is no reported data.

Before taking Cinnarizin 25mg Domesco medicine for peripheral vascular disease (3 blisters x 10 tablets)

How to use

cinnarizin 25mg tablets for oral tablets.

cinnarizin should be taken after meals.

Dosage

adults

Peripheral disease: The usual dose is 50 - 75 mg (2 - 3 capsules) x 2-3 times/day. Do not exceed the usual dose.

Peripheral artery disease: Slow improvement when treated with drugs. The maximum effect of cinnarizin will appear after a few weeks of continuous treatment, although significantly improving blood flow has been proven after 1 week.

Elderly: like adults.

Children: DisecLe

What do

do when overdose?

Common signs and symptoms of cinnarizin overdose:

Different changes in consciousness, from drowsiness to drowsiness and coma, vomiting, foreign symptoms and tone reduction.

In some children causing epileps.

Most cases of non -serious clinical consequences, but the death has been reported after overdose of cinnarizin and drugs containing cinnarizin.

How to deal with overdose drugs:

There is no specific antidote. In case of overdose, symptom treatment and support. Can use activated carbon if necessary.

Actively monitor for timely management measures.

What to do when you forget the dose? If the time is close to the next medication, skip the forgotten dose and take the next dose at the usual time. Do not use double dose to compensate for the forgotten dose. In case of taking too many tablets: Meet the doctor immediately or go to the recovery department - emergency of the nearest hospital.

Side Effects

When using Cinnarizin 25mg, you may experience unwanted effects (ADR).

Based on synthetic safety data from clinical trials, the most common reaction (> 2 %) is drowsiness and weight gain.

The following unwanted reactions are collected from clinical trials and experience after using cinnarizin.

Summary of unwanted reactions:

Agencies Frequency (*) Unwanted reactions Love

Unknown Mobility disorders, symptoms of foreign tapes, Parkinson, Run

Uncommon discomfort in the stomach, vomiting, abdominal pain, indigestion Flat, Lupus erythematosus in the skin. Common Weight gain

Very common (ADR ≥ 1/10), common (1/100 ≤ ADR Instructions on how to handle ADR: can prevent drowsiness and digestive disorders, often temporary, by gradually increasing the dose to the optimal level. Must stop the drug when the disease is worse or see the symptoms of outsider when long -term treatment for the elderly.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

contraindicated

cinnarizin 25mg contraindicated in the following case patient with a history of hypersensitivity to cinnarizin or any other ingredient of the drug.

Caution when using

as well as other antihistamines, cinnarizin can cause discomfort in the upper region.

Taking medicine after meals can reduce stomach irritation.

cinnarizin does not reduce blood pressure significantly. However, caution should be used in patients with hypotension.

In patients with Parkinson's disease, only cinnarizin if the benefits are greater than the risks that worsen the disease.

cinnarizin can cause drowsiness, especially when starting treatment. Therefore, it is necessary to be cautious when used with alcohol or medication inhibitors of the central nervous system or three -round antidepressants.

Avoid using cinnarizin in patients with porphyrin metabolic disorders.

There is no research in liver or kidney dysfunction. Should be used carefully in patients with liver or renal failure.

Because the drug contains lactose. Patients with galactose tolerance problems, patients with lapp lactase or glucose-galactose abutments should not be used.

affects the ability to drive and operate machinery

cinnarizin can cause drowsiness, especially when starting treatment. Therefore, do not drive or operate machinery when taking the drug.

Pregnant and lactating women

During pregnancy: There is no data on the safety of cinnarizin during pregnancy in humans, although animal studies have proven not to cause teratogenicity. Cinnarizin should not be used in pregnant women.

Breastfeeding period: There is no data on the excretion of cinnarizin in breast milk. Therefore, cinnarizin should not be used in breastfeeding people.

Medicinal interaction

simultaneous use of cinnarizin with alcohol, central nervous system inhibitors or three -round antidepressants can increase the sedative effect of these drugs or cinnarizin.

Diagnostic effects: Due to the antihistamine effect, cinnarizin can prevent positive skin reaction indicators if using cinnarizin 4 days before testing.

Cavalry of the drug: Because there is no studies on the taboos of oral drugs, not mixing this drug with other drugs

Storage

Store in: dry place, temperature below 30 ° C, avoid light.

Storage in the original packaging of the drug.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.